Inozyme Pharma Inc.

NASDAQ: INZY · Real-Time Price · USD
4.00
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM

Inozyme Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
21.08M 34.59M 32.91M 23.32M
Short-Term Investments
92.01M 154M 94.95M 88.48M
Long-Term Investments
n/a n/a 354K 354K
Other Long-Term Assets
1.16M 2M 3.81M 3.41M
Receivables
467K 385K 115K 62K
Inventory
n/a n/a -115K -62K
Other Current Assets
311K n/a n/a n/a
Total Current Assets
120.68M 196.25M 131.39M 115.34M
Property-Plant & Equipment
1.35M 2.59M 3.64M 4.44M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.51M 4.6M 7.8M 8.2M
Total Assets
123.18M 200.85M 139.19M 123.54M
Account Payables
2.53M 1.17M 2.54M 2.39M
Deferred Revenue
n/a n/a 3.81M n/a
Short-Term Debt
15.41M n/a 816K 731K
Other Current Liabilities
12.29M 8.77M 7.74M 5.4M
Total Current Liabilities
33.9M 14.69M 14.71M 11.63M
Long-Term Debt
31.46M 44.77M 4.14M n/a
Other Long-Term Liabilities
n/a n/a 124K n/a
Total Long-Term Liabilities
31.46M 45.68M 6.09M 2.64M
Total Liabilities
65.36M 60.37M 20.8M 14.27M
Total Debt
46.87M 46.59M 6.78M 3.37M
Common Stock
6K 6K 4K 2K
Retained Earnings
-387.95M -285.93M -214.76M -147.7M
Comprehensive Income
69K 41K -205K 18K
Shareholders Equity
57.83M 140.48M 118.59M 109.27M
Total Investments
92.01M 154M 94.95M 88.48M